2m 2m 2m 2m 2m 2m 2m
SAVARA (SVRA)
NASDAQ
$5.75+$0.06 (+1.02%)
Price as of Jun 23, 2026 7:56 PM EDT- $1.2BMarket Cap
- 163.43%1-Year Change
- BiotechnologyIndustry
SAVARA (SVRA)
$5.75+$0.06 (+1.02%)
SVRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.69 | ||
Change | +$0.19 (+3.45%) | ||
Open | $5.59 | ||
High | $5.79 | ||
Low | $5.50 | ||
Previous Close | $5.50 | ||
Volume | 2,291,438 | ||
30-Day Average Volume | 1,804,951 | ||
1-Week Change | 6.75% | ||
1-Month Change | 13.35% | ||
1-Year Change | 163.43% | ||
3-Year Change | 94.86% | ||
5-Year Change | 234.71% | ||
Fundamentals | |||
Shares Outstanding | 204.9M | ||
Total Assets | $221.6M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$37.3M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $193.7M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -38 | ||
PEG | 3 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue